Michael Mason
2019
In 2019, Michael Mason earned a total compensation of $956.7K as Senior Vice President, Chief Financial Officer and Treasurer at Karyopharm Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $75,000 |
|---|---|
| Option Awards | $529,935 |
| Salary | $340,332 |
| Other | $11,430 |
| Total | $956,697 |
Mason received $529.9K in option awards, accounting for 55% of the total pay in 2019.
Mason also received $75K in non-equity incentive plan, $340.3K in salary and $11.4K in other compensation.
Rankings
In 2019, Michael Mason's compensation ranked 9,463rd out of 13,971 executives tracked by ExecPay. In other words, Mason earned more than 32.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,463 out of 13,971 | 32nd |
Division Manufacturing | 3,804 out of 5,701 | 33rd |
Major group Chemicals And Allied Products | 1,441 out of 2,200 | 35th |
Industry group Drugs | 1,230 out of 1,886 | 35th |
Industry Pharmaceutical Preparations | 915 out of 1,398 | 35th |
Source: SEC filing on April 7, 2021.
Mason's colleagues
We found three more compensation records of executives who worked with Michael Mason at Karyopharm Therapeutics in 2019.